176 related articles for article (PubMed ID: 37245038)
1. Effect of prophylactic antiviral intervention on T cell immunity in hepatitis B virus-infected pregnant women.
Huang M; Gao Y; Liao D; Ma Y; Li J; Tang B; Hao Y; Zhang X; Yin S; Jiang X; Li J; Yin X; Li Y; Hu J; Liu Z
BMC Pregnancy Childbirth; 2023 May; 23(1):392. PubMed ID: 37245038
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
3. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
4. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.
Zhang L; Jiang T; Yang Y; Deng W; Lu H; Wang S; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Yang L; Bi X; Lin Y; Lu Y; Jiang Y; Li M; Xie Y
Front Immunol; 2022; 13():1112234. PubMed ID: 36685527
[TBL] [Abstract][Full Text] [Related]
5. Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare.
Huang M; Gao Y; Yin X; Zhang X; Hao Y; Hu J; Liu Z
BMC Infect Dis; 2021 Sep; 21(1):922. PubMed ID: 34488681
[TBL] [Abstract][Full Text] [Related]
6. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between HBeAg from HBsAg positive mothers and regulatory T cells in neonates and its influence on HBV intrauterine transmission].
Hao HY; Yang ZQ; Xu XX; Wang XF; Wang B; Shi XH; Fu ZD; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1410-1414. PubMed ID: 29060990
[No Abstract] [Full Text] [Related]
8. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
[TBL] [Abstract][Full Text] [Related]
9. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
Chang HL; Wen WH; Lee CN; Chiu YE; Liu CJ; Chang MH; Lin LH; Chen HL
J Viral Hepat; 2022 Feb; 29(2):107-114. PubMed ID: 34724288
[TBL] [Abstract][Full Text] [Related]
11. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
13. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
14. Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.
Li Y; Wang J; Yu Y; Qiu C; Li Z; Ling Q; Zhang G; Li L; Gong Y; Lu Q; Cao L; Gu T; Wang X; Zhang M; Zhang Q; Zhang H; Xu B; Shao L; Pu Y; Zhang W
Liver Int; 2020 Oct; 40(10):2377-2384. PubMed ID: 32304160
[TBL] [Abstract][Full Text] [Related]
15. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
16. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
17. The role of caesarean section and nonbreastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg-and HBeAg-positive mothers: results from a prospective cohort study and a meta-analysis.
Pan YC; Jia ZF; Wang YQ; Yang N; Liu JX; Zhai XJ; Song Y; Wang C; Li J; Jiang J
J Viral Hepat; 2020 Oct; 27(10):1032-1043. PubMed ID: 32362050
[TBL] [Abstract][Full Text] [Related]
18. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity.
Lu H; Cao W; Zhang L; Yang L; Bi X; Lin Y; Deng W; Jiang T; Sun F; Zeng Z; Lu Y; Zhang L; Liu R; Gao Y; Wu S; Hao H; Chen X; Hu L; Xu M; Xiong Q; Dong J; Song R; Li M; Xie Y
Front Immunol; 2023; 14():1122048. PubMed ID: 36875136
[TBL] [Abstract][Full Text] [Related]
19. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring.
Khamduang W; Gaudy-Graffin C; Ngo-Giang-Huong N; Jourdain G; Moreau A; Borkird T; Layangool P; Kamonpakorn N; Jitphiankha W; Kwanchaipanich R; Potchalongsin S; Lallemant M; Sirirungsi W; Goudeau A;
J Clin Virol; 2013 Oct; 58(2):415-21. PubMed ID: 23916828
[TBL] [Abstract][Full Text] [Related]
20. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
